Profil
Nilay Thakar, Ph.D is a Principal with ARCH Venture Partners, joining the company as an Associate in 2018.
Dr. Thakar focuses on company creation, identifying and evaluating new life sciences technologies, and providing operating assistance to early-stage portfolio companies.
Dr. Thakar is a co-founder of Skylark Bio and supported investments in Ally Therapeutics and One BioMed.
Aktive Positionen von Nilay Thakar
| Unternehmen | Position | Beginn |
|---|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private-Equity-Analyst | - |
Skylark Bio, Inc.
Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Direktor/Vorstandsmitglied | - |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology Operates as a biotechnology platform that develops isolated microbes for agriculture industry | Direktor/Vorstandsmitglied | 01.02.2022 |
Ehemalige bekannte Positionen von Nilay Thakar
| Unternehmen | Position | Ende |
|---|---|---|
Australian Institute For Bioengineering & Nanotechnology | Corporate Officer/Principal | 01.08.2016 |
Emma's Secret Investments Pty Ltd.
Emma's Secret Investments Pty Ltd. Other Consumer ServicesConsumer Services Provides beauty and spa therapy services | Berater | 01.07.2016 |
Ausbildung von Nilay Thakar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology Operates as a biotechnology platform that develops isolated microbes for agriculture industry | Health Technology |
Australian Institute For Bioengineering & Nanotechnology | |
Emma's Secret Investments Pty Ltd.
Emma's Secret Investments Pty Ltd. Other Consumer ServicesConsumer Services Provides beauty and spa therapy services | Consumer Services |
Skylark Bio, Inc.
Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Health Technology |
















